Mallinckrodt   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: St Louis MO United States (1867)
Status: Acquired by Avon Products (1982) → now International Minerals and Chemical Corporation (1986)

Organization Overview

First Clinical Trial
1998
NCT00005773
First Marketed Drug
1947
methadone (methadose)
First NDA Approval
1968
iodohippurate sodium i-131 (Hipputope)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Mallinckrodt | MALLINCKRODT | MALLINCKRODT ARD | MALLINCKRODT HOSP | Mallinckrodt, Inc. | MALLINCKRODT INC | MALLINCKRODT IRELAND | Mallinckrodt Pharma IP Trading DAC | Mallinckrodt (v1) | Mallinckrodt (v2) | MALLINKRODT NUCLEAR